{
  "meta": {
    "title": "Clinical_Biochemistry",
    "url": "https://brainandscalpel.vercel.app/clinical-biochemistry-716081ee.html",
    "scrapedAt": "2025-11-30T07:37:10.588Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">HbS exhibits faster electrophoretic mobility than HbA</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydroxyurea causes Inhibiting polymerization of sickle hemoglobin</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickle cell trait provides protection against endemic malaria</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">The substitution of valine for glutamic acid results in structural alternation in Hemoglobin produces sickle Hemoglobin.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following statements about sickle cell disease are true except </span></p>",
      "unique_key": "DT1295624",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295624,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option A: </strong>Hemoglobin S (HbS) has a different electrical charge than normal hemoglobin A (HbA) due to the substitution of valine for glutamic acid in the beta-globin chain. This change in charge causes HbS to move faster toward the anode in electrophoresis at an alkaline pH.</p>\r\n<p><strong>Option B: </strong>Hydroxyurea, a medication used to manage sickle cell disease, does not directly inhibit the polymerization of HbS. Instead, it increases the production of fetal hemoglobin (HbF), which reduces the overall proportion of HbS in red blood cells. Increased HbF levels reduce sickling episodes because HbF does not participate in the polymerization that leads to the formation of rigid, sickle-shaped cells.</p>\r\n<p><strong>Option C: </strong>Individuals with sickle cell trait (who are heterozygous for HbS, carrying one sickle cell gene and one normal gene) have some protection against malaria, particularly <em>Plasmodium falciparum</em>, the most deadly form of malaria. This protective effect is believed to result from changes in the red blood cells that make it harder for the malaria parasite to survive and proliferate.</p>\r\n<p><strong>Option D: </strong>Sickle cell disease results from a single-point mutation in the beta-globin gene, where valine (a hydrophobic amino acid) replaces glutamic acid (a negatively charged amino acid) at the sixth position of the beta-globin chain. This substitution alters hemoglobin's structure and decreases its solubility, causing hemoglobin molecules to polymerize under low oxygen conditions, leading to the characteristic sickle shape of red blood cells.</p>\r\n<p><strong>Detailed explanation about Sickel cell anemia</strong></p>\r\n<p>Cause and Genetics</p>\r\n<ul>\r\n<li>Mutation: Sickle cell anemia is caused by a mutation in the beta-globin gene on chromosome 11.</li>\r\n<li>Amino Acid Substitution: The mutation leads to the substitution of valine for glutamic acid at the sixth position of the beta-globin chain, forming hemoglobin S (HbS).</li>\r\n<li>Inheritance Pattern: It is inherited in an autosomal recessive manner. Individuals with two copies of the HbS gene (HbSS) have sickle cell disease, while those with one copy (HbAS) have sickle cell trait, which is usually asymptomatic.</li>\r\n</ul>\r\n<p>Pathophysiology</p>\r\n<ul>\r\n<li>Sickle Cell Formation: Under low oxygen conditions, HbS molecules polymerize, causing red blood cells to take on a rigid, sickle shape.</li>\r\n<li>Reduced RBC Lifespan: Sickle cells have a shorter lifespan (10&ndash;20 days) than normal red blood cells (120 days), leading to chronic hemolytic anemia.</li>\r\n<li>Vaso-Occlusion: Sickled cells can block small blood vessels, leading to pain (vaso-occlusive crises) and organ damage.</li>\r\n</ul>\r\n<p>Clinical Features</p>\r\n<ul>\r\n<li>Painful Crises: Episodes of severe pain due to vasoocclusion, often affecting the bones, joints, chest, and abdomen.</li>\r\n<li>Anemia: Fatigue, pallor, and jaundice are common due to chronic hemolysis.</li>\r\n<li>Increased Susceptibility to Infection: Especially with encapsulated organisms (e.g., Streptococcus pneumoniae) due to functional asplenia (auto-splenectomy).</li>\r\n<li>Growth and Development: Delayed growth and puberty are often observed in children with sickle cell anemia.</li>\r\n</ul>\r\n<p>Complications</p>\r\n<ul>\r\n<li>Acute Chest Syndrome: A severe lung complication that is one of the leading causes of mortality; symptoms include chest pain, fever, and respiratory distress.</li>\r\n<li>Stroke: Increased risk of stroke, particularly in children with sickle cell disease.</li>\r\n<li>Splenic Sequestration: A potentially life-threatening condition where large amounts of blood pool in the spleen.</li>\r\n<li>Organ Damage: Chronic organ damage, particularly to the spleen, liver, kidneys, and heart.</li>\r\n<li>Priapism: Painful, prolonged erections due to blood vessel blockage in the penis.</li>\r\n</ul>\r\n<p>Diagnosis</p>\r\n<ul>\r\n<li>Newborn Screening: Early diagnosis through newborn screening programs, typically by hemoglobin electrophoresis or HPLC.</li>\r\n<li>Hemoglobin Electrophoresis: Confirms the presence of HbS and distinguishes between sickle cell disease and sickle cell trait.</li>\r\n<li>Blood Smear: Shows sickle-shaped red blood cells, target cells, and Howell-Jolly bodies (indicating asplenia).</li>\r\n</ul>\r\n<p>Management</p>\r\n<ul>\r\n<li>Hydroxyurea: Increases fetal hemoglobin (HbF) levels, reducing the frequency of sickling and pain crises.</li>\r\n<li>Pain Management: Includes hydration, pain medications, and sometimes blood transfusions.</li>\r\n<li>Infection Prevention: Prophylactic antibiotics and vaccinations, especially against encapsulated bacteria.</li>\r\n<li>Blood Transfusions: Used in severe cases or to manage specific complications like stroke or acute chest syndrome.</li>\r\n<li>Curative Treatment: Bone marrow or stem cell transplant is the only potential cure but is limited by donor availability and risk factors.</li>\r\n</ul>\r\n<p>Prognosis</p>\r\n<ul>\r\n<li>Life Expectancy: With modern care, individuals with sickle cell disease have a significantly improved life expectancy but still face challenges from chronic complications.</li>\r\n<li>Quality of Life: Regular medical care, pain management, and support can help improve quality of life.</li>\r\n</ul>\r\n<p>Sickle Cell Trait</p>\r\n<ul>\r\n<li>Protective Effect Against Malaria: Carriers of one HbS gene (sickle cell trait) have partial protection against Plasmodium falciparum malaria, particularly in endemic regions.</li>\r\n<li>Usually Asymptomatic: Individuals with sickle cell trait are typically asymptomatic but may experience complications under extreme conditions like intense physical exertion, dehydration etc</li>\r\n</ul>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Mutation in sickle cell anemia: Substitution of valine for glutamic acid at the sixth position of the beta-globin chain, produces HbS</li>\r\n<li>Protective Effect Against Malaria</li>\r\n<li>Hydroxyurea: Increases fetal hemoglobin (HbF) levels, reducing the frequency of sickling and pain crises.</li>\r\n</ul>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">How many genes are deleted in haemoglobin H disease</span></p>",
      "unique_key": "DT1295953",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295953,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option C: </strong>Hemoglobin H disease is a form of alpha-thalassemia where three of the four alpha-globin genes are deleted. Each person typically has two alpha-globin genes on each chromosome 16, totalling four alpha-globin genes. When three of these genes are deleted, it leads to hemoglobin H disease, characterized by an excess of beta chains that form abnormal hemoglobin (HbH), resulting in mild to moderate anemia and other related symptoms.</p>\r\n<p><strong>Option A &amp; Option B: </strong>1 or 2 genes deleted result in alpha-thalassemia trait, which is often asymptomatic or mildly symptomatic.</p>\r\n<p><strong>Option D: </strong>4 genes deleted results in a more severe condition called hydrops fetalis with Hb Bart's, which is usually fatal in utero or shortly after birth.</p>\r\n<p><strong>Detailed explanation about </strong><strong>Thalassemia</strong></p>\r\n<p>Thalassemias are a group of inherited blood disorders characterized by reduced or absent production of one of the globin chains that make up hemoglobin, the protein in red blood cells responsible for carrying oxygen. The condition leads to ineffective red blood cell production and anemia.</p>\r\n<p>There are two main types of thalassemia, alpha and beta, depending on which globin chain (alpha or beta) is affected.</p>\r\n<p><strong>Alpha Thalassemia</strong></p>\r\n<p>Cause</p>\r\n<ul>\r\n<li>Caused by mutations or deletions in the alpha-globin genes (located on chromosome 16). Humans normally have 4 alpha-globin genes&mdash;2 on each chromosome 16. The severity of the disease depends on how many of these genes are deleted or mutated.</li>\r\n</ul>\r\n<p>Types of Alpha Thalassemia:</p>\r\n<ul>\r\n<li>Silent Carrier: 1 gene deleted; no symptoms, but can pass on the gene.</li>\r\n<li>Alpha Thalassemia Trait (Minor): 2 genes deleted; mild anemia or no symptoms at all. Often detected on routine blood tests.</li>\r\n<li>Hemoglobin H Disease: 3 genes deleted; moderate anemia, enlargement of the spleen (splenomegaly), and other mild symptoms. HbH (hemoglobin with 4 beta chains) is produced.</li>\r\n<li>Alpha Thalassemia Major (Hydrops Fetalis): 4 genes deleted; this is the most severe form and is often fatal in utero or shortly after birth due to the formation of Hb Bart's, an abnormal hemoglobin with 4 gamma chains, which cannot carry oxygen effectively.</li>\r\n</ul>\r\n<p>Symptoms (depending on severity):</p>\r\n<ul>\r\n<li>Fatigue, pallor, and weakness</li>\r\n<li>Splenomegaly and hepatomegaly</li>\r\n<li>Bone deformities (especially in severe cases)</li>\r\n<li>Growth retardation and delayed puberty</li>\r\n</ul>\r\n<p>Treatment:</p>\r\n<ul>\r\n<li>Mild cases may not require treatment, but regular blood tests and monitoring are important.</li>\r\n<li>Severe cases may require blood transfusions, iron chelation therapy (to manage iron overload), and occasionally bone marrow or stem cell transplant.</li>\r\n</ul>\r\n<p><strong>Beta Thalassemia</strong></p>\r\n<p>Cause</p>\r\n<ul>\r\n<li>Caused by mutations or deletions in the beta-globin genes (located on chromosome 11). Humans have two beta-globin genes, one on each chromosome 11. Beta thalassemia can vary in severity depending on the nature of the mutation.</li>\r\n</ul>\r\n<p>Types of Beta Thalassemia:</p>\r\n<ul>\r\n<li>Beta Thalassemia Minor (Trait): One beta-globin gene is mutated, causing mild anemia, but usually no symptoms. This is often detected incidentally.</li>\r\n<li>Beta Thalassemia Intermedia: Both beta-globin genes are affected, leading to moderate to severe anemia, but not requiring regular blood transfusions in some cases.</li>\r\n<li>Beta Thalassemia Major (Cooley's Anemia): Both beta-globin genes are severely affected, leading to severe anemia that requires regular blood transfusions to survive. Without treatment, it can lead to serious complications such as iron overload, heart failure, and organ damage.</li>\r\n</ul>\r\n<p>Symptoms of Beta Thalassemia Major:</p>\r\n<ul>\r\n<li>Severe anemia (pallor, fatigue, weakness)</li>\r\n<li>Failure to thrive (in children)</li>\r\n<li>Enlarged spleen (splenomegaly) and liver (hepatomegaly)</li>\r\n<li>Bone deformities (especially facial bones and skull)</li>\r\n<li>Iron overload due to frequent blood transfusions, leading to damage to organs like the heart and liver.</li>\r\n</ul>\r\n<p>Treatment:</p>\r\n<ul>\r\n<li>Regular blood transfusions.</li>\r\n<li>Iron chelation therapy to manage iron overload caused by repeated transfusions.</li>\r\n<li>Bone marrow or stem cell transplant may offer a potential cure in some patients.</li>\r\n<li>Supportive care to manage complications.</li>\r\n</ul>\r\n<p>&nbsp;</p>\r\n<p><strong>Diagnosis of Thalassemia</strong></p>\r\n<ul>\r\n<li>Hemoglobin Electrophoresis: A test that separates different types of hemoglobin, helping to detect abnormal forms like HbA2, HbF, or HbS.</li>\r\n<li>Complete Blood Count (CBC): Can show anemia with microcytosis (small red blood cells) and hypochromia (pale red blood cells).</li>\r\n<li>Genetic Testing: Confirms the mutations or deletions in the alpha or beta-globin genes.</li>\r\n</ul>\r\n<p><strong>Prevention and Carrier Screening</strong></p>\r\n<ul>\r\n<li>Carrier Screening: People with a family history of thalassemia, or those from populations where thalassemia is common (e.g., Mediterranean, African, Southeast Asian), should undergo carrier screening before pregnancy to assess their risk of passing on the disorder.</li>\r\n<li>Prenatal Diagnosis: If both parents are carriers, prenatal genetic testing (such as chorionic villus sampling or amniocentesis) can determine if the fetus is affected.</li>\r\n</ul>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Thalassemias is inherited disorders characterized by reduced or absent production of one of the globin chains.</li>\r\n<li>Alpha thalassemia caused by mutations or deletions in the alpha-globin genes (located on chromosome 16).</li>\r\n<li>Beta thalassemia caused by mutations or deletions in the beta-globin genes (located on chromosome 11).</li>\r\n</ul>",
      "correct_choice_id": 13,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Leptin</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Interleukin-6 (IL-6)</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Ghrelin</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Adiponectin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not considered an adipokine?</span></p>",
      "unique_key": "DT1295955",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295955,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011060631b77-235e-43a3-935c-213a4f6cc8b2.jpg\"><p>Ghrelin is not considered an adipokine because it is primarily produced by the stomach, unlike leptin, IL-6, and adiponectin, which are produced by adipose tissue and are classified as adipokines.</p>\r\n<p><strong>Detailed explanation about Adipokines</strong></p>\r\n<p>Definition</p>\r\n<ul>\r\n<li>Adipokines are bioactive molecules (hormones, cytokines, and other proteins) secreted by adipose tissue (fat cells).</li>\r\n<li>They play crucial roles in metabolism, inflammation, and immune responses and act on various organs, including the liver, muscles, brain, and cardiovascular system.</li>\r\n</ul>\r\n<p>Types of Adipokines</p>\r\n<ul>\r\n<li>Leptin: Regulates appetite and energy balance by signalling the brain to reduce hunger. High in individuals with excess fat, although resistance to leptin may develop in obesity.</li>\r\n<li>Adiponectin: Enhances insulin sensitivity, has anti-inflammatory effects, and promotes fatty acid oxidation. Levels decrease with increased body fat, especially in obesity.</li>\r\n<li>Resistin: Associated with insulin resistance and inflammation; its levels are typically higher in obesity and may link adiposity with diabetes.</li>\r\n<li>Interleukin-6 (IL-6): Although primarily an inflammatory cytokine, IL-6 is also released by adipose tissue. It contributes to low-grade inflammation in obesity and plays a role in insulin resistance.</li>\r\n<li>Tumor Necrosis Factor-alpha (TNF-&alpha;): A pro-inflammatory cytokine that contributes to insulin resistance and is elevated in obesity.</li>\r\n<li>Plasminogen Activator Inhibitor-1 (PAI-1): Involved in blood clotting; elevated levels are linked to an increased risk of cardiovascular disease in obesity.</li>\r\n</ul>\r\n<p>Roles in Health and Disease</p>\r\n<ul>\r\n<li>Adipokines are essential in regulating energy balance, glucose metabolism, lipid metabolism, and immune responses.</li>\r\n<li>Obesity: Excess fat, particularly in visceral adipose tissue, alters adipokine secretion. This imbalance contributes to chronic inflammation, insulin resistance, and other metabolic conditions.</li>\r\n<li>Metabolic Syndrome: Adipokine dysregulation is a significant factor in developing metabolic syndrome, which includes hypertension, insulin resistance, and dyslipidemia.</li>\r\n<li>Cardiovascular Disease: Certain adipokines (e.g., IL-6, TNF-&alpha;, PAI-1) are linked to atherosclerosis and other cardiovascular conditions due to their pro-inflammatory and pro-coagulant effects.</li>\r\n<li>Adiponectin improves insulin sensitivity, promoting glucose uptake and reducing the risk of diabetes. Leptin and resistin are involved in pathways that can lead to insulin resistance, particularly when secreted at high levels in obesity.</li>\r\n<li>Adipose tissue, especially in obesity, produces inflammatory adipokines like IL-6 and TNF-&alpha;, leading to chronic low-grade inflammation. This inflammation contributes to the development of type 2 diabetes, cardiovascular disease, and other obesity-related complications.</li>\r\n<li>Understanding adipokines has led to interest in targeting these molecules for therapeutic strategies in obesity, diabetes, cardiovascular disease, and other inflammatory disorders. Therapies aimed at increasing adiponectin or modulating leptin sensitivity are areas of research interest.</li>\r\n</ul>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Adipokines are bioactive molecules (hormones, cytokines, and other proteins) secreted by adipose tissue (fat cells).</li>\r\n<li>Examples are: Leptin, Adiponectin, Resistin, Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-&alpha;), Plasminogen Activator Inhibitor-1 (PAI-1), Visfatin, Chemerin</li>\r\n<li>Leptin: Regulates appetite and energy balance by signalling the brain to reduce hunger. High in individuals with excess fat, although resistance to leptin may develop in obesity.</li>\r\n</ul>",
      "correct_choice_id": 23,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Stimulating insulin secretion</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibiting glucagon release</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Prolonging the action of incretin hormones</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Increasing glucose excretion in urine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">DPP-4 inhibitors help manage blood glucose levels by:</span></p>",
      "unique_key": "DT1295957",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295957,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option A: </strong>DPP-4 inhibitors do not directly stimulate insulin release. Instead, they work by prolonging the action of incretin hormones (GLP-1 and GIP). These incretin hormones help to increase insulin secretion in response to meals, but only when blood glucose levels are elevated. This makes insulin release more glucose-dependent, reducing the risk of hypoglycemia.</p>\r\n<p><strong>Option B: </strong>DPP-4 inhibitors also help to reduce glucagon levels, but this effect is indirect. By preserving incretin hormone action, DPP-4 inhibitors support lower glucagon secretion, especially after meals. Lower glucagon levels reduce the amount of glucose the liver releases into the bloodstream, helping to prevent high blood sugar levels.</p>\r\n<p><strong>Option C: </strong>DPP-4 inhibitors work by blocking the enzyme dipeptidyl peptidase-4 (DPP-4), which is responsible for breaking down incretin hormones (GLP-1 and GIP). By inhibiting DPP-4, these medications extend the life of incretin hormones in the blood. These hormones help regulate blood glucose by increasing insulin secretion and reducing glucagon levels in a glucose-dependent manner, making them particularly useful in managing post-meal blood glucose levels.</p>\r\n<p><strong>Option D: </strong>Increasing glucose excretion in the urine is the primary effect of a different class of medications called SGLT2 inhibitors (e.g., empagliflozin, dapagliflozin). SGLT2 inhibitors work by blocking the reabsorption of glucose in the kidneys, allowing excess glucose to be excreted in the urine, thereby lowering blood glucose levels.</p>\r\n<p><strong>Detailed explanation </strong></p>\r\n<p>DPP-4 inhibitors (Dipeptidyl Peptidase-4 inhibitors) are a class of oral medications used to manage type 2 diabetes by helping to regulate blood glucose levels. They work by prolonging the action of incretin hormones, which play a key role in glucose metabolism.</p>\r\n<p>Key Points About DPP-4 Inhibitors:</p>\r\n<p>Mechanism of Action:</p>\r\n<ul>\r\n<li>DPP-4 inhibitors block the enzyme dipeptidyl peptidase-4 (DPP-4), which is responsible for breaking down incretin hormones, primarily GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide).</li>\r\n<li>By inhibiting DPP-4, these drugs increase the levels and prolong the action of GLP-1 and GIP in the blood, enhancing their effects on insulin and glucagon regulation.</li>\r\n<li>The incretin effect increases insulin secretion from the pancreas in response to meals and inhibits glucagon release from the pancreas, both of which help lower blood glucose levels in a glucose-dependent manner.</li>\r\n</ul>\r\n<p>Effects on Blood Glucose:</p>\r\n<ul>\r\n<li>Post-meal glucose control: DPP-4 inhibitors are especially effective at lowering blood glucose after meals (postprandial glucose).</li>\r\n<li>Low risk of hypoglycemia: Since they enhance insulin secretion only when blood glucose is elevated, DPP-4 inhibitors carry a lower risk of causing hypoglycemia compared to some other diabetes medications.</li>\r\n</ul>\r\n<p>Common DPP-4 Inhibitors:</p>\r\n<ul>\r\n<li>Sitagliptin (Januvia)</li>\r\n<li>Saxagliptin (Onglyza)</li>\r\n<li>Linagliptin (Tradjenta)</li>\r\n<li>Alogliptin (Nesina)</li>\r\n</ul>\r\n<p>Side Effects:</p>\r\n<ul>\r\n<li>DPP-4 inhibitors are generally well-tolerated but can cause mild side effects, including nasopharyngitis (cold symptoms), headache, and digestive issues like nausea.</li>\r\n<li>Pancreatitis: There have been reports of pancreatitis in patients taking DPP-4 inhibitors, so these medications are used cautiously in people with a history of pancreatitis.</li>\r\n</ul>\r\n<p>Contraindication</p>\r\n<ul>\r\n<li>Type 1 diabetes: These medications are not used in type 1 diabetes since they rely on functional beta-cell activity.</li>\r\n<li>Pancreatitis history: Patients with a history of pancreatitis should avoid DPP-4 inhibitors due to a possible risk of recurrence.</li>\r\n</ul>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>DPP-4 inhibitors block the enzyme dipeptidyl peptidase-4 (DPP-4), which is responsible for breaking down incretin hormones, primarily GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide).</li>\r\n<li>By inhibiting DPP-4, these drugs increase the levels and prolong the action of GLP-1 and GIP in the blood, enhancing their effects on insulin and glucagon regulation.</li>\r\n<li>The incretin effect increases insulin secretion from the pancreas in response to meals and inhibits glucagon release from the pancreas.</li>\r\n</ul>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Beta HCG</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">CA 125</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen receptor </span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Prostate specific antigen </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which tumor marker is important for detection of ovarian cancer </span></p>",
      "unique_key": "DT1295959",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295959,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501101991c1a2-d600-440c-b0c8-9980ea66a0d2.jpg\">\r\n<p>Here&rsquo;s a list of important tumor markers and the cancers they are typically associated with:</p>\r\n<ol>\r\n<li>CA 125 &ndash; Ovarian cancer</li>\r\n<li>PSA (Prostate-Specific Antigen) &ndash; Prostate cancer</li>\r\n<li>AFP (Alpha-Fetoprotein) &ndash; Liver cancer (Hepatocellular carcinoma), Germ cell tumors (testicular, ovarian)</li>\r\n<li>Beta HCG (Human Chorionic Gonadotropin) &ndash; Germ cell tumors (testicular, ovarian), Gestational trophoblastic disease</li>\r\n<li>CEA (Carcinoembryonic Antigen) &ndash; Colorectal cancer, Pancreatic cancer, Breast cancer, Lung cancer</li>\r\n<li>CA 19-9 &ndash; Pancreatic cancer, Gastrointestinal cancers (e.g., colorectal, gastric)</li>\r\n<li>HER2/neu &ndash; Breast cancer (HER2-positive)</li>\r\n<li>BRCA1/BRCA2 &ndash; Breast and Ovarian cancer (hereditary)</li>\r\n<li>LDH (Lactate Dehydrogenase) &ndash; Lymphomas, Leukemias, Melanoma, Other cancers</li>\r\n<li>S-100 &ndash; Melanoma</li>\r\n<li>Vimentin &ndash; Sarcomas, Melanoma</li>\r\n<li>Thyroglobulin &ndash; Thyroid cancer (Papillary and Follicular)</li>\r\n<li>P16 &ndash; HPV-related cancers (e.g., Cervical cancer, Oropharyngeal cancer)</li>\r\n<li>Mucin-16 (MUC16) &ndash; Ovarian cancer</li>\r\n<li>NSE (Neuron-Specific Enolase) &ndash; Small cell lung cancer, Neuroendocrine tumors</li>\r\n<li>CYFRA 21-1 &ndash; Non-small cell lung cancer</li>\r\n<li>CTC (Circulating Tumor Cells) &ndash; Various cancers (e.g., Breast, Prostate, Colorectal)</li>\r\n<li>APF (Acid Phosphatase) &ndash; Prostate cancer</li>\r\n<li>Trop-2 &ndash; Various cancers (e.g., Breast cancer)</li>\r\n<li>CA 15-3 &ndash; Breast cancer</li>\r\n</ol>\r\n<p>These tumor markers are commonly used for diagnosis, monitoring treatment, and detecting recurrence of various cancers.</p>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>CA 125 &ndash; Ovarian cancer</li>\r\n<li>PSA (Prostate-Specific Antigen) &ndash; Prostate cancer</li>\r\n<li>AFP (Alpha-Fetoprotein) &ndash;Hepatocellular carcinoma, Germ cell tumors</li>\r\n<li>Beta HCG (Human Chorionic Gonadotropin) &ndash; Germ cell tumors, Gestational trophoblastic disease</li>\r\n<li>CEA (Carcinoembryonic Antigen) &ndash; Colorectal cancer, Pancreatic cancer, Breast cancer, Lung cancer</li>\r\n<li>CA 19-9 &ndash; Pancreatic cancer, Gastrointestinal cancers (e.g., colorectal, gastric)</li>\r\n</ul>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">RB gene retinoblastoma</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">ras gene</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">p53 gene</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">FAP gene familial adenomatous polyposis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are Oncosuppressor gene except </span></p>",
      "unique_key": "DT1295962",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295962,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501104674e3f6-f46e-412a-9fff-8088b667dc44.jpg\">\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>RB, p53, and FAP (APC) genes are tumor suppressor (oncosuppressor) genes because they help regulate the cell cycle and prevent the development of cancer.</li>\r\n<li>Ras gene is an oncogene and is not a tumor suppressor. When mutated, it promotes uncontrolled cell growth.</li>\r\n</ul>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">a-1, b-2, c-3</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">a-2, b-1, c-3</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">a-3. b-1, c-2</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">a-1, b-3, c-2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are mechanisms related with activation of proto-oncogene to oncogene <br>Match the following<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110507fe534-2313-4165-8d28-df3ddccf9603.jpg\"></span></p>",
      "unique_key": "DT1295969",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295969,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110372168f8-ccb5-4615-bd25-647b1e7fb1b0.jpg\"><p><strong>So, Option A is correct match.</strong></p>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Promoter insertion associated with myc gene</li>\r\n<li>Chromosomal translocation associated with c-abl gene</li>\r\n<li>Gene amplification associated with ras gene</li>\r\n</ul>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver cancer</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervical cancer</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Burkitt's lymphoma</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Kaposi's sarcoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What type of cancer is primarily associated with the Epstein-Barr virus (EBV)?</span></p>",
      "unique_key": "DT1295970",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295970,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011064d43112-cb4d-4470-9902-b0091bdc5294.jpg\">\r\n<p>Here&rsquo;s a list of key oncogenic viruses and the cancers they are associated with:</p>\r\n<ol>\r\n<li>Epstein-Barr virus (EBV) &ndash; Burkitt's lymphoma, Nasopharyngeal carcinoma, Hodgkin's lymphoma</li>\r\n<li>Human papillomavirus (HPV) &ndash; Cervical cancer, Anal cancer, Oropharyngeal cancer, Penile cancer, Vulvar cancer</li>\r\n<li>Hepatitis B virus (HBV) &ndash; Liver cancer (Hepatocellular carcinoma)</li>\r\n<li>Hepatitis C virus (HCV) &ndash; Liver cancer (Hepatocellular carcinoma)</li>\r\n<li>Human herpesvirus 8 (HHV-8) &ndash; Kaposi's sarcoma, Primary effusion lymphoma, Castleman's disease</li>\r\n<li>Human T-lymphotropic virus 1 (HTLV-1) &ndash; Adult T-cell leukemia/lymphoma (ATLL)</li>\r\n<li>Merkel cell polyomavirus (MCV) &ndash; Merkel cell carcinoma</li>\r\n<li>Cytomegalovirus (CMV) &ndash; Post-transplant lymphoproliferative disorder (PTLD) (in immunocompromised individuals)</li>\r\n</ol>\r\n<p>These viruses are linked to the development of specific cancers through mechanisms such as persistent infection, immune evasion, and alterations in host cell DNA.</p>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Epstein-Barr virus (EBV) &ndash; Burkitt's lymphoma</li>\r\n<li>Human papillomavirus (HPV) &ndash; Cervical cancer</li>\r\n<li>Hepatitis B virus (HBV) &amp; Hepatitis C virus (HCV) &ndash; Liver cancer</li>\r\n</ul>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevated waist circumference</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevated blood pressure</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Low HDL cholesterol levels</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevated white blood cell count</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is NOT a criterion for diagnosing metabolic syndrome according to the National Cholesterol Education Program (NCEP) guidelines?</span></p>",
      "unique_key": "DT1295971",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295971,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option A: </strong>An elevated waist circumference is used to assess abdominal obesity, which is a key component of metabolic syndrome. The thresholds for waist circumference vary by gender and ethnicity.</p>\r\n<p><strong>Option B: </strong>Elevated blood pressure (systolic &ge; 130 mmHg or diastolic &ge; 85 mmHg) is another criterion for diagnosing metabolic syndrome. Hypertension is a significant risk factor for cardiovascular diseases and is a key feature of metabolic syndrome.</p>\r\n<p><strong>Option C: </strong>Low HDL cholesterol (less than 40 mg/dL for men and less than 50 mg/dL for women) is one of the diagnostic criteria for metabolic syndrome. HDL is known as \"good cholesterol,\" and low levels are associated with an increased risk of heart disease.</p>\r\n<p><strong>Option D: </strong>An elevated white blood cell count (WBC) is not a criterion for diagnosing metabolic syndrome. While elevated WBC can be indicative of inflammation or infection, it is not a specific marker for metabolic syndrome according to the NCEP guidelines.</p>\r\n<p><strong>Detailed explanation</strong></p>\r\n<p>According to the National Cholesterol Education Program (NCEP) guidelines, Metabolic Syndrome is diagnosed when a person has at least three or more of the following criteria:</p>\r\n<ol>\r\n<li>Elevated waist circumference: This reflects abdominal obesity, which is a key feature of metabolic syndrome.\r\n<ul>\r\n<li>Men: &ge; 40 inches (102 cm)</li>\r\n<li>Women: &ge; 35 inches (88 cm)</li>\r\n</ul>\r\n</li>\r\n<li>Elevated blood pressure:\r\n<ul>\r\n<li>Systolic BP &ge; 130 mmHg or Diastolic BP &ge; 85 mmHg or currently on antihypertensive medication.</li>\r\n</ul>\r\n</li>\r\n<li>Elevated triglyceride levels:\r\n<ul>\r\n<li>Triglycerides &ge; 150 mg/dL or on treatment for high triglycerides.</li>\r\n</ul>\r\n</li>\r\n<li>Low HDL cholesterol levels:\r\n<ul>\r\n<li>Men: &lt; 40 mg/dL</li>\r\n<li>Women: &lt; 50 mg/dL</li>\r\n<li>Or, if on treatment for low HDL cholesterol.</li>\r\n</ul>\r\n</li>\r\n<li>Elevated fasting glucose:\r\n<ul>\r\n<li>Fasting glucose &ge; 100 mg/dL or on treatment for elevated glucose (i.e., diabetes or prediabetes).</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<p>To be diagnosed with metabolic syndrome under the NCEP guidelines, a person must have at least 3 of these 5 criteria. It&rsquo;s important to note that the presence of metabolic syndrome increases the risk for cardiovascular diseases and type 2 diabetes</p>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>As per NCEP guidelines, Metabolic Syndrome criteria are: Elevated waist circumference, Elevated blood pressure, Elevated triglyceride levels, Low HDL cholesterol levels, Elevated fasting glucose</li>\r\n</ul>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Human T-cell Lymphotropic virus</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis B virus</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Epstein Barr virus</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Human Papilloma Virus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following in not a DNA oncogenic virus?</span></p>",
      "unique_key": "DT1295973",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295973,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110762ce870-86d4-43d6-ace3-6ca19faae0af.jpg\">\r\n<p><strong>Detailed explanation</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250110cf227feb-74f8-42ba-80a2-73fac0dd0e24.jpg\">\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>DNA Oncogenic Viruses: HBV, EBV, HPV, MCV</li>\r\n<li>RNA Oncogenic Viruses: HTLV-1, HCV, HIV (indirectly)</li>\r\n</ul>",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha 1 antitrypsin is also called alpha 1 antiproteinase</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha 1 antitrypsin deficiency is associated with liver disease</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Long term smoking coupled with genetic deficiency of  alpha 1 antitrypsin predisposes to emphysema </span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha 1 antitrypsin inhibits elastase activity and causes proteolytic damage of the lung tissue.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are true about alpha 1 antitrypsin except</span></p>",
      "unique_key": "DT1296043",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296043,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option A: </strong>Alpha-1 antitrypsin (A1AT) is also known as alpha-1 antiproteinase. A1AT is a serine protease inhibitor produced mainly in the liver. It is a part of the serpin (serine protease inhibitor) family, specifically inhibiting proteolytic enzymes (proteases) that break down proteins.</p>\r\n<p>The primary role of A1AT is to protect tissues from enzymes, like neutrophil elastase, that are released during inflammation. These proteolytic enzymes, if not regulated, can cause damage to healthy tissues.</p>\r\n<p>A1AT is produced in the liver, it circulates in the bloodstream and is particularly active in the lungs, where it protects lung tissue from excessive proteolytic damage.</p>\r\n<p><strong>Option B: </strong>A1AT deficiency can lead to liver disease. This condition is usually caused by mutations in the SERPINA1 gene, which affect the production and folding of A1AT in liver cells.</p>\r\n<p>In severe forms of deficiency, A1AT proteins are misfolded and cannot be secreted properly from liver cells. This misfolded A1AT accumulates in the hepatocytes (liver cells) and can form clumps or aggregates. These aggregates can lead to chronic liver damage and increase the risk of liver diseases such as hepatitis, cirrhosis, and even hepatocellular carcinoma. Symptoms can appear in both children and adults, though the severity varies.</p>\r\n<p><strong>Option C: </strong>Smoking releases free radicals and other toxic substances that deplete A1AT levels and increase elastase activity in the lungs. In individuals with A1AT deficiency, smoking accelerates the damage to lung tissue because they lack adequate levels of A1AT to inhibit elastase effectively.</p>\r\n<p>Together, smoking and A1AT deficiency significantly increase the risk and speed of developing emphysema, with symptoms often appearing earlier and being more severe.</p>\r\n<p><strong>Option D: </strong>A1AT&rsquo;s primary function is to inhibit neutrophil elastase and other proteolytic enzymes that, if uncontrolled, could damage lung tissue. Neutrophil elastase is released by neutrophils (a type of white blood cell) during inflammation and infection to break down pathogens. However, if left unchecked, elastase can damage lung tissue and lead to diseases like emphysema.</p>\r\n<p>A deficiency in A1AT removes this protective effect, which allows elastase to break down elastin in the lung tissue, causing emphysema. Thus, A1AT is protective, and its deficiency (not its presence) is associated with lung damage.</p>\r\n<p><strong>Detailed explanation about </strong><strong>Alpha-1 antitrypsin (A1AT)</strong></p>\r\n<p><strong>Definition: </strong>Alpha-1 antitrypsin (A1AT) is a protein, also known as alpha-1 antiproteinase, primarily produced in the liver. It is part of the serpin (serine protease inhibitor) family.</p>\r\n<p><strong>Function: </strong>The main role of A1AT is to inhibit neutrophil elastase, a protease enzyme that, if uncontrolled, can degrade lung tissue elastin. By inhibiting elastase, A1AT protects lung and other tissues from proteolytic damage during inflammation.</p>\r\n<p><strong>Genetic Deficiency: </strong>A1AT deficiency is an inherited condition caused by mutations in the SERPINA1 gene. The deficiency can lead to decreased levels of A1AT or production of dysfunctional A1AT, which cannot be properly secreted from liver cells.</p>\r\n<p><strong>Inheritance Pattern: </strong>A1AT deficiency follows an autosomal codominant inheritance pattern, meaning that both alleles contribute to A1AT production. Two abnormal alleles (homozygous) result in a more severe deficiency.</p>\r\n<p><strong>Associated Diseases:</strong></p>\r\n<ul>\r\n<li>Lung Disease: A1AT deficiency is a major risk factor for emphysema, a type of chronic obstructive pulmonary disease (COPD). The deficiency allows unchecked elastase activity, leading to lung tissue damage.</li>\r\n<li>Liver Disease: Misfolded A1AT proteins can accumulate in liver cells, causing liver diseases like hepatitis, cirrhosis, and hepatocellular carcinoma.</li>\r\n</ul>\r\n<p><strong>Risk Factors: </strong>Long-term smoking exacerbates lung damage in people with A1AT deficiency. Smoking depletes A1AT levels and increases elastase activity, accelerating lung tissue breakdown.</p>\r\n<p><strong>Symptoms of Deficiency:</strong></p>\r\n<ul>\r\n<li>Lung-related: Shortness of breath, wheezing, chronic cough, and susceptibility to respiratory infections.</li>\r\n<li>Liver-related: Jaundice, fatigue, and in severe cases, liver failure.</li>\r\n</ul>\r\n<p><strong>Diagnosis: </strong>A1AT deficiency is diagnosed through blood tests measuring A1AT levels, genetic tests for SERPINA1 mutations, and sometimes liver biopsy for patients with liver involvement.</p>\r\n<p><strong>Treatment:</strong></p>\r\n<ul>\r\n<li>Augmentation Therapy: Replacement of A1AT protein via intravenous infusion to maintain protective levels in the bloodstream, particularly for lung disease.</li>\r\n<li>Lifestyle Changes: Smoking cessation is crucial, as smoking significantly worsens outcomes.</li>\r\n<li>Liver Transplant: For severe liver disease due to A1AT deficiency, a liver transplant may be considered.</li>\r\n</ul>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Alpha-1 antitrypsin is anti-proteinase protein (serine protease inhibitor)</li>\r\n<li>Primarily produced in the liver</li>\r\n<li>Main role is to inhibit neutrophil elastase, protects lung and other tissues from proteolytic damage during inflammation.</li>\r\n<li>A1AT deficiency can lead to emphysema, aggravated by smoking</li>\r\n<li>Misfolded A1AT proteins can accumulate in liver cells, causing liver diseases</li>\r\n</ul>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Leukemia</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Hodgkin's lymphoma</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-Hodgkin's lymphoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following hematological malignancies is commonly associated with kidney dysfunction and proteinuria?</span></p>",
      "unique_key": "DT1296687",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296687,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<p><strong>Option A: </strong>Leukemia is a type of blood cancer that originates in the bone marrow, where abnormal white blood cells are produced. While leukemia can cause various systemic effects, kidney dysfunction and proteinuria are less commonly associated with it compared to other hematological malignancies. However, in advanced cases, leukemia cells can infiltrate the kidneys, leading to renal impairment, but this is not a primary characteristic.</p>\r\n<p><strong>Option B: </strong>Hodgkin&rsquo;s lymphoma is a type of lymphoma that involves the lymphatic system, primarily affecting lymph nodes. Although renal impairment can occasionally occur due to factors like treatment toxicity or paraneoplastic syndromes, kidney dysfunction and proteinuria are not commonly seen in Hodgkin's lymphoma itself.</p>\r\n<p><strong>Option C: </strong>Multiple myeloma is strongly associated with kidney dysfunction and proteinuria. In multiple myeloma, abnormal plasma cells produce excessive amounts of immunoglobulin proteins, particularly light chains (also called Bence Jones proteins), which can accumulate in the kidneys. These proteins can cause cast nephropathy (also known as \"myeloma kidney\") and lead to kidney damage.</p>\r\n<p><strong>Option D: </strong>Non-Hodgkin's lymphoma is a group of blood cancers that originates in lymphoid tissue, including lymph nodes and other lymphatic organs. Renal involvement is possible but less common and not as strongly associated with proteinuria as in multiple myeloma. Kidney dysfunction can occur due to factors like direct tumor infiltration, compression, or treatment-related side effects, but it is not as typical or diagnostic as in multiple myeloma.</p>\r\n<p><strong>Detailed explanation about Multiple Myeloma</strong></p>\r\n<p><strong>Definition: </strong>Multiple myeloma is a type of blood cancer originating from plasma cells in the bone marrow. In multiple myeloma, abnormal plasma cells multiply uncontrollably, producing excess immunoglobulins (proteins), particularly monoclonal (M) proteins or light chains.</p>\r\n<p><strong>Symptoms </strong></p>\r\n<ul>\r\n<li>Bone Pain: Most commonly in the spine and ribs due to bone lesions.</li>\r\n<li>Fractures: Weakened bones are prone to fractures.</li>\r\n<li>Anemia: Caused by crowding out of normal bone marrow cells, leading to fatigue.</li>\r\n<li>Frequent Infections: Due to impaired antibody production.</li>\r\n<li>Hypercalcemia: Elevated calcium levels from bone breakdown, causing confusion, constipation, and other symptoms.</li>\r\n<li><strong>Bone Involvement: </strong>Multiple myeloma causes osteolytic bone lesions, where abnormal plasma cells stimulate osteoclast activity, breaking down bone tissue, leading to bone pain and fractures.</li>\r\n<li><strong>Kidney Dysfunction (Myeloma Kidney):</strong>\r\n<ul>\r\n<li>Proteinuria: Abnormal plasma cells produce excessive light chains (Bence Jones proteins) that are filtered by the kidneys, which can accumulate and cause kidney damage.</li>\r\n<li>Cast Nephropathy: These proteins can form casts in renal tubules, leading to blockages and renal impairment, known as \"myeloma kidney.\"</li>\r\n<li>Kidney Complications: Kidney dysfunction is a common complication, often indicated by elevated creatinine levels and proteinuria, and may progress to kidney failure if untreated.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>CRAB Criteria: </strong>Key features that help diagnose and assess multiple myeloma severity include:</p>\r\n<ul>\r\n<li>C: Calcium elevation (hypercalcemia)</li>\r\n<li>R: Renal dysfunction</li>\r\n<li>A: Anemia</li>\r\n<li>B: Bone lesions (lytic lesions or osteoporosis)</li>\r\n</ul>\r\n<p><strong>Diagnosis:</strong></p>\r\n<ul>\r\n<li>Blood Tests: Elevated serum protein and the presence of M protein in the blood (monoclonal spike on serum protein electrophoresis).</li>\r\n<li>Urine Tests: Presence of Bence Jones proteins (light chains) in urine.</li>\r\n<li>Bone Marrow Biopsy: Increased plasma cells in the bone marrow.</li>\r\n<li>Imaging: X-rays, MRI, or CT scans show lytic lesions in bones.</li>\r\n</ul>\r\n<p><strong>Treatment:</strong></p>\r\n<ul>\r\n<li>Chemotherapy and Targeted Therapy: Drugs like bortezomib, lenalidomide, and daratumumab.</li>\r\n<li>Stem Cell Transplant: Autologous stem cell transplant is often considered.</li>\r\n<li>Supportive Care: Bisphosphonates for bone health, hydration for kidney protection, and management of hypercalcemia.</li>\r\n</ul>\r\n<p><strong>Prognosis: </strong>The prognosis has improved with newer therapies, but multiple myeloma remains incurable. Treatment focuses on prolonging remission and managing symptoms.</p>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>In multiple myeloma, abnormal plasma cells multiply uncontrollably, producing excess immunoglobulins, particularly monoclonal (M) proteins or light chains.</li>\r\n<li>CRAB Criteria (To diagnose and assess severity): C: Calcium elevation (hypercalcemia), R: Renal dysfunction, A: Anemia, B: Bone lesions (lytic lesions or osteoporosis)</li>\r\n<li>Monoclonal spike on serum protein electrophoresis (M Band)</li>\r\n<li>Urine Tests shows presence of Bence Jones proteins (light chains) in urine.</li>\r\n</ul>",
      "correct_choice_id": 113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Hematuria</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Proteinuria</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Edema</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoalbuminemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a characteristic feature of nephrotic syndrome?</span></p>",
      "unique_key": "DT1296689",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296689,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<p><strong>Option A: </strong>Hematuria (presence of blood in urine) is not a characteristic feature of nephrotic syndrome. Nephrotic syndrome is primarily defined by proteinuria, edema, hypoalbuminemia, and hyperlipidemia.</p>\r\n<p>Hematuria is more common in nephritic syndrome and is not a defining feature of nephrotic syndrome.</p>\r\n<p><strong>Option B, Option C, Option D: </strong>Proteinuria (excessive protein in the urine) is a hallmark of nephrotic syndrome. In nephrotic syndrome, proteinuria is often severe, with the loss of more than 3.5 grams of protein per day, which contributes to other symptoms such as hypoalbuminemia and edema.</p>\r\n<p><strong>Detailed explanation</strong></p>\r\n<p>The diagnostic features of nephrotic syndrome include the following key laboratory and clinical findings:</p>\r\n<ol>\r\n<li>Heavy Proteinuria:\r\n<ul>\r\n<li>Proteinuria is defined as the excretion of more than 3.5 grams of protein per 24 hours in adults.</li>\r\n<li>This high level of protein loss occurs due to damage to the glomerular filtration barrier in the kidneys, allowing large proteins like albumin to leak into the urine.</li>\r\n</ul>\r\n</li>\r\n<li>Hypoalbuminemia:\r\n<ul>\r\n<li>Low levels of albumin in the blood (typically &lt;3.0 g/dL).</li>\r\n<li>Due to excessive protein loss in the urine, serum albumin levels drop. This contributes to low oncotic pressure in the blood, leading to fluid imbalance and edema.</li>\r\n</ul>\r\n</li>\r\n<li>Edema:\r\n<ul>\r\n<li>Edema (swelling) is often seen in the legs, around the eyes (periorbital edema), and in the abdomen (ascites).</li>\r\n<li>Hypoalbuminemia reduces oncotic pressure, causing fluid to shift from the bloodstream into tissues, leading to edema.</li>\r\n</ul>\r\n</li>\r\n<li>Hyperlipidemia:\r\n<ul>\r\n<li>Elevated blood levels of cholesterol, triglycerides, and other lipids.</li>\r\n<li>The liver compensates for protein loss by increasing protein synthesis, including lipoproteins, leading to elevated lipid levels in the blood (hypercholesterolemia and hypertriglyceridemia).</li>\r\n</ul>\r\n</li>\r\n<li>Lipiduria (optional but supportive finding):\r\n<ul>\r\n<li>The presence of lipids or \"fatty casts\" in the urine, which may appear as oval fat bodies or \"Maltese crosses\" under polarized light microscopy.</li>\r\n<li>Lipiduria is not essential for diagnosis but often accompanies hyperlipidemia in nephrotic syndrome.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Hematuria is not a characteristic feature of nephrotic syndrome; it is more commonly associated with nephritic syndrome.</li>\r\n<li>Nephrotic syndrome is defined by the triad of proteinuria, hypoalbuminemia, and edema.</li>\r\n</ul>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperalbuminemia</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypercholesterolemia</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypocalcemia</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoglycemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following laboratory findings is typically seen in nephrotic syndrome?</span></p>",
      "unique_key": "DT1296731",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296731,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<p><strong>Option A: </strong>Nephrotic syndrome is characterized by hypoalbuminemia (not hyperalbuminemia) due to excessive protein loss in the urine. This protein loss reduces serum albumin levels, contributing to edema and other symptoms.</p>\r\n<p><strong>Option B: </strong>Hypercholesterolemia (elevated cholesterol levels) is a typical finding in nephrotic syndrome. Due to the loss of proteins, the liver responds by increasing the production of proteins, including lipoproteins, which leads to elevated levels of cholesterol and other lipids in the blood. This hyperlipidemia is a hallmark feature of nephrotic syndrome.</p>\r\n<p><strong>Option C: </strong>Hypocalcemia (low levels of calcium in the blood) can also occur in nephrotic syndrome, though it is not a primary diagnostic feature. The loss of albumin, which binds calcium in the blood, can result in lower total calcium levels. However, ionized (free) calcium often remains normal, so the hypocalcemia is usually mild and related to hypoalbuminemia.</p>\r\n<p><strong>Option D: </strong>Hypoglycemia (low blood sugar) is not typically associated with nephrotic syndrome. Nephrotic syndrome does not directly affect blood glucose levels.</p>\r\n<p><strong>Detailed explanation</strong></p>\r\n<p>The diagnostic features of nephrotic syndrome include the following key laboratory and clinical findings:</p>\r\n<ol>\r\n<li>Heavy Proteinuria:\r\n<ul>\r\n<li>Proteinuria is defined as the excretion of more than 3.5 grams of protein per 24 hours in adults.</li>\r\n<li>This high level of protein loss occurs due to damage to the glomerular filtration barrier in the kidneys, allowing large proteins like albumin to leak into the urine.</li>\r\n</ul>\r\n</li>\r\n<li>Hypoalbuminemia:\r\n<ul>\r\n<li>Low levels of albumin in the blood (typically &lt;3.0 g/dL).</li>\r\n<li>Due to excessive protein loss in the urine, serum albumin levels drop. This contributes to low oncotic pressure in the blood, leading to fluid imbalance and edema.</li>\r\n</ul>\r\n</li>\r\n<li>Edema:\r\n<ul>\r\n<li>Edema (swelling) is often seen in the legs, around the eyes (periorbital edema), and in the abdomen (ascites).</li>\r\n<li>Hypoalbuminemia reduces oncotic pressure, causing fluid to shift from the bloodstream into tissues, leading to edema.</li>\r\n</ul>\r\n</li>\r\n<li>Hyperlipidemia:\r\n<ul>\r\n<li>Elevated blood levels of cholesterol, triglycerides, and other lipids.</li>\r\n<li>The liver compensates for protein loss by increasing protein synthesis, including lipoproteins, leading to elevated lipid levels in the blood (hypercholesterolemia and hypertriglyceridemia).</li>\r\n</ul>\r\n</li>\r\n<li>Lipiduria (optional but supportive finding):\r\n<ul>\r\n<li>The presence of lipids or \"fatty casts\" in the urine, which may appear as oval fat bodies or \"Maltese crosses\" under polarized light microscopy.</li>\r\n<li>Lipiduria is not essential for diagnosis but often accompanies hyperlipidemia in nephrotic syndrome.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>The <strong>classic triad</strong> for diagnosing nephrotic syndrome includes:\r\n<ul>\r\n<li><strong>Heavy proteinuria (&gt;3.5 g/day)</strong></li>\r\n<li><strong>Hypoalbuminemia (&lt;3.0 g/dL)</strong></li>\r\n<li><strong>Edema</strong></li>\r\n</ul>\r\n</li>\r\n<li>Often accompanied by <strong>hyperlipidemia</strong></li>\r\n</ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">C-reactive protein (CRP)</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">CA 125</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferritin</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum amyloid A (SAA)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is NOT an acute-phase protein?</span></p>",
      "unique_key": "DT1296734",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296734,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<p><strong>Option A: </strong>C-reactive protein (CRP) is a well-known acute-phase protein. It is produced by the liver in response to inflammation, infection, and tissue injury. CRP levels increase rapidly in acute inflammatory states and are widely used as a marker of inflammation.</p>\r\n<p><strong>Option B: </strong>CA 125 is not an acute-phase protein. It is a tumor marker, primarily associated with ovarian cancer, and is used to monitor the disease. CA 125 may also increase in other conditions (e.g., endometriosis or liver disease), but it is not involved in the acute-phase response.</p>\r\n<p><strong>Option C: </strong>Ferritin, an iron-storage protein, also functions as an acute-phase protein. During inflammation, ferritin levels increase as part of the body&rsquo;s response to infection or tissue damage. This helps in sequestering iron away from pathogens and modulating the immune response.</p>\r\n<p><strong>Option D: </strong>Serum amyloid A (SAA) is another acute-phase protein produced by the liver in response to inflammatory cytokines. It plays a role in the immune response and is typically elevated in infections, inflammation, and tissue injury.</p>\r\n<p><strong>Detailed explanation</strong></p>\r\n<p><strong>Definition: </strong>Acute-phase proteins (APPs) are a group of plasma proteins whose concentrations change in response to inflammation, infection, trauma, or other tissue injuries.</p>\r\n<p>The production of acute-phase proteins is primarily regulated by inflammatory cytokines like IL-6, IL-1, and TNF-&alpha;. IL-6 is one of the main cytokines responsible for upregulating positive APPs.</p>\r\n<p><strong>Function: </strong>The main role of APPs is to help modulate and enhance the body&rsquo;s immune response. They aid in defence mechanisms such as:</p>\r\n<ul>\r\n<li>Limiting microbial growth by sequestering essential nutrients (e.g., iron).</li>\r\n<li>Facilitating phagocytosis and clearance of pathogens or damaged cells.</li>\r\n<li>Modulating inflammation and protecting tissues from excessive damage.</li>\r\n</ul>\r\n<p><strong>Types of Acute-Phase Proteins:</strong></p>\r\n<ul>\r\n<li>Positive APPs: These proteins increase in concentration during inflammation. Examples include:\r\n<ul>\r\n<li>C-reactive protein (CRP): An important marker for inflammation, it activates the complement system and enhances phagocytosis.</li>\r\n<li>Serum amyloid A (SAA): Involved in immune response modulation and tissue repair.</li>\r\n<li>Ferritin: Stores iron and limits its availability to pathogens during infection.</li>\r\n<li>Fibrinogen: A coagulation factor that helps in clot formation to control bleeding and limit infection spread.</li>\r\n<li>Haptoglobin: Binds free hemoglobin to prevent oxidative damage.</li>\r\n</ul>\r\n</li>\r\n<li>Negative APPs: These proteins decrease in concentration during the acute-phase response. Examples include albumin and transferrin.</li>\r\n</ul>\r\n<p><strong>Clinical Significance:</strong></p>\r\n<ul>\r\n<li>CRP levels are commonly used laboratory markers to assess inflammation and disease activity in conditions like infections, autoimmune diseases, and inflammatory conditions.</li>\r\n<li>Used to monitor disease progression, response to treatment, and prognosis in inflammatory diseases.</li>\r\n</ul>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Examples of Common Acute-Phase Proteins: C-Reactive Protein (CRP), Serum Amyloid A (SAA), Ferritin, Fibrinogen, Haptoglobin, Complement Components (e.g., C3, C4)</li>\r\n</ul>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis </span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis </span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following conditions is characterized by decreased pH (<7.35) and decreased bicarbonate (HCO3-) levels (<22 mEq/L)?</span></p>",
      "unique_key": "DT1296736",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296736,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250116dcecec0d-082c-429d-9d31-fe1105d3d851.jpg\">\r\n<p>Normal pH is 7.35 to 7.45 (7.40), pCO2 is 35 to 45 mm Hg (40 mm Hg) &amp; Bicarbonate level is 22 to 26 mmol/L (24 mmol/L).</p>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>In Respiratory acidosis, pH is low, pCO2 is high &amp; bicarbonate is normal or high.</li>\r\n<li>In Respiratory alkalosis, pH is high, pCO2 is low &amp; bicarbonate is normal or low.</li>\r\n<li>In Metabolic acidosis, pH is low, pCO2 is normal or low &amp; bicarbonate is low.</li>\r\n<li>In Metabolic alkalosis, pH is high, pCO2 is normal of high &amp; bicarbonate is high.</li>\r\n</ul>",
      "correct_choice_id": 153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis </span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following conditions can result from prolonged vomiting or excessive diuretic use? </span></p>",
      "unique_key": "DT1296738",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296738,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250116c9e40457-e6f4-4774-9cfc-a65d164d6596.jpg\">\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Respiratory acidosis: Common causes are COPD, Sedatives</li>\r\n<li>Respiratory alkalosis: Common causes are Anxiety, Sepsis, High attitude</li>\r\n<li>Metabolic acidosis: DKA, Lactic acidosis, Diarrhea, Renal failure</li>\r\n<li>Metabolic alkalosis: Sever Vomiting, Diuretics, Antacid</li>\r\n</ul>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">pH of extracellular fluid </span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">pH of intracellular fluid </span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">pH of blood plasma </span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">pH of cerebrospinal fluid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The bicarbonate buffer system primarily regulates which of the following? </span></p>",
      "unique_key": "DT1296740",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296740,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501162e100299-4cf3-45b5-8dec-cc58f514bacc.jpg\">\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Extracellular buffer &ndash; Bicarbonate buffer</li>\r\n<li>Intracellular Buffer &ndash; Phosphate buffer</li>\r\n<li>Buffer in blood &ndash; Plasma protein (albumin) &amp; Hemoglobin in RBC</li>\r\n<li>Urinary buffer &ndash; Phosphate buffer</li>\r\n</ul>",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Absorbing excess acids or bases to maintain pH within a narrow range </span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Releasing excess acids or bases to maintain pH within a narrow range </span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Converting acids into bases and bases into acids to maintain pH within a narrow range</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Buffer systems function by: </span></p>",
      "unique_key": "DT1296743",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296743,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<p><strong>Option A: </strong>Buffer systems function by absorbing excess hydrogen ions (H+) when the pH is too low (acidic) or absorbing hydroxide ions (OH-) when the pH is too high (basic). This prevents significant fluctuations in pH. <br />Example: The bicarbonate buffer system neutralizes excess H+ (forming H2CO3) or neutralizes OH- (forming HCO3-).</p>\r\n<p><strong>Option B: </strong>Buffers do not \"release\" acids or bases directly. Instead, they adjust ion concentrations through reversible reactions. For example, bicarbonate reacts with H+ or OH-, but it does not actively \"release\" them.</p>\r\n<p><strong>Option C: </strong>Buffers do not \"convert\" acids into bases or vice versa. Instead, they neutralize or minimize their effects by reversible reactions, stabilizing the pH without changing their fundamental nature.</p>\r\n<p><strong>Option D: </strong>Option A correctly explains the function of buffers.</p>\r\n<p><strong>Detailed explanation about Buffers</strong></p>\r\n<p>Definition: Buffers are solutions that resist changes in pH when small amounts of acid (H+) or base (OH-) are added.</p>\r\n<p>Components of a Buffer</p>\r\n<ol>\r\n<li>Weak acid (HA): Donates H+ when pH rises.</li>\r\n<li>Conjugate base (A-): Accepts H+ when pH drops.</li>\r\n</ol>\r\n<p>Example: In the bicarbonate buffer system, H2CO3 (weak acid) and HCO3- (conjugate base).</p>\r\n<p>How Buffers Work: Operate on the principle of Le Chatelier's Principle, maintaining equilibrium:</p>\r\n<ul>\r\n<li>If acid (H+) is added: Conjugate base neutralizes H+.</li>\r\n<li>If base (OH-) is added: Weak acid donates H+ to neutralize OH-.</li>\r\n</ul>\r\n<p>Buffer Capacity: The ability of a buffer to resist pH changes. It depends on:</p>\r\n<ol>\r\n<li>Concentration of buffer components (higher concentration = higher capacity).</li>\r\n<li>pKa of the buffer: Maximum buffering occurs when pH &asymp; pKa.</li>\r\n</ol>\r\n<p>Examples of Biological Buffers</p>\r\n<ol>\r\n<li>Bicarbonate Buffer System (H2CO3/HCO3-): Regulates blood pH, ECF pH</li>\r\n</ol>\r\n<p>Reaction: CO2 + H2O &hArr; H2CO3 &hArr; H+ + HCO3-</p>\r\n<ol>\r\n<li>Phosphate Buffer System (H2PO4-/HPO4&sup2;-): Maintains intracellular pH.</li>\r\n<li>Protein Buffers: Histidine residues in hemoglobin buffer blood during oxygen transport.</li>\r\n</ol>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Buffers are solutions that resist changes in pH when small amounts of acid (H+) or base (OH-) are added.</li>\r\n<li>Examples of Biological Buffers: Bicarbonate, Phosphate and protein buffers</li>\r\n</ul>",
      "correct_choice_id": 181,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloride and bicarbonate </span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Bicarbonate and phosphate </span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Bicarbonate and sulfate </span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloride and phosphate </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The anion gap is calculated by subtracting the sum of which two ions from the sum of sodium and potassium ions? </span></p>",
      "unique_key": "DT1296744",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296744,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<p><strong>Option A: </strong>The anion gap is calculated as: [Na+] + [K+] - ([Cl-] + [HCO3-])</p>\r\n<p>Sodium (Na+) and potassium (K+) are the major cations.</p>\r\n<p>Chloride (Cl-) and bicarbonate (HCO3-) are the major measurable anions.</p>\r\n<p>The difference represents unmeasured anions (e.g., lactate, phosphate, sulfates, proteins).</p>\r\n<p>Potassium (K+) is often excluded for simplicity in some clinical settings:</p>\r\n<p>Anion Gap=[Na+]&minus;([Cl-]+[HCO3-])</p>\r\n<p>Normal Range: 8&ndash;12 mEq/L (without K+) or 12&ndash;16 mEq/L (with K+).</p>\r\n<p>Understanding the anion gap is crucial for diagnosing and managing acid-base disorders effectively.</p>\r\n<p><strong>Option B: </strong>Phosphate is not a primary component of the anion gap calculation because it is not routinely measured in standard blood panels. Instead, it is part of the unmeasured anions.</p>\r\n<p><strong>Option C: </strong>Sulfate is also an unmeasured anion and is not directly included in the anion gap formula. It contributes to the unmeasured portion but is not subtracted in the calculation.</p>\r\n<p><strong>Option D: </strong>While chloride is part of the calculation, phosphate is an unmeasured anion, not subtracted directly. The anion gap formula focuses on chloride and bicarbonate.</p>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Formula of Anion Gap = ([Na+] + [K+]) &minus; ([Cl-] + [HCO3-])</li>\r\n<li>Normal Range: 12&ndash;16 mEq/L (with K+).</li>\r\n<li>Normal Anion Gap Acidosis caused by loss of bicarbonate, e.g., diarrhea or renal tubular acidosis.</li>\r\n<li>Increased Anion Gap: Indicates metabolic acidosis due to unmeasured anions like lactic acidosis, ketosis, (DKA, Starvation ketosis), Toxins e.g., methanol, ethylene glycol.</li>\r\n</ul>",
      "correct_choice_id": 191,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal tubular acidosis </span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis </span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis </span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetic ketoacidosis </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An elevated urine anion gap suggests: </span></p>",
      "unique_key": "DT1296746",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296746,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<p><strong>Option A: </strong>The urine anion gap (UAG) is an indirect way to assess the kidneys' ability to excrete ammonium (NH4+). It is calculated as:</p>\r\n<p><strong>UAG= </strong>([Na+] + [K+]) &minus; ([Cl-])</p>\r\n<p>An elevated UAG suggests a reduced ability of the kidneys to excrete ammonium, as seen in renal tubular acidosis (RTA). Normally, ammonium excretion is accompanied by chloride (Cl-), making the UAG negative. In RTA, ammonium excretion is impaired, causing the UAG to become positive or less negative.</p>\r\n<p><strong>Option B: </strong>In metabolic alkalosis, the kidneys typically retain hydrogen ions (H+) and excrete bicarbonate (HCO3-). This condition does not directly affect ammonium excretion to the extent seen in RTA. The UAG is less relevant here.</p>\r\n<p><strong>Option C: </strong>Respiratory alkalosis is caused by hyperventilation, leading to low arterial CO2. While it can alter urine chemistry slightly (e.g., more bicarbonate excretion), it does not result in a positive UAG.</p>\r\n<p><strong>Option D: </strong>In Diabetic ketoacidosis (DKA), the kidneys compensate for the metabolic acidosis by increasing ammonium excretion. This increases urinary chloride excretion, making the UAG negative. Therefore, DKA is associated with a negative UAG, not an elevated one.</p>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Urine anion gap (UAG) is an indirect way to assess the kidneys' ability to excrete ammonium ions (NH4<sup>+</sup>).</li>\r\n<li>It is calculated as: UAG= ([Na+] + [K+]) &minus; ([Cl-])</li>\r\n<li>A positive UAG points to impaired renal ammonium excretion, characteristic of renal tubular acidosis. In other causes of metabolic acidosis like DKA, the UAG becomes negative.</li>\r\n</ul>",
      "correct_choice_id": 201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphate buffer system</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory buffer system</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Bicarbonate buffer system</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Protein buffer system</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a primary buffer system in the blood that helps maintain pH within a normal range?</span></p>",
      "unique_key": "DT1296747",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296747,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<p><strong>Option A: </strong>The phosphate buffer system (H2PO4-/HPO4&sup2;-) is more active in intracellular fluids and the kidneys than in blood. It plays a minor role in blood pH regulation because phosphate concentrations in plasma are relatively low.</p>\r\n<p><strong>Option B: </strong>The respiratory buffer system refers to how breathing regulates CO2 levels, which indirectly influences the bicarbonate buffer system. While critical for pH balance, it is not a chemical buffer system itself but rather a physiological mechanism for regulating blood CO2.</p>\r\n<p><strong>Option C: </strong>The bicarbonate buffer system is the most important buffer system in blood plasma for maintaining pH within the normal range (7.35&ndash;7.45).</p>\r\n<p>It involves the equilibrium: CO<sub>2 </sub>+ H<sub>2</sub>O &harr; H<sub>2</sub>CO<sub>3</sub> &harr; H<sup>+</sup> + HCO3<sup>&minus; </sup></p>\r\n<p>Carbon dioxide (CO2) from metabolism combines with water (H2O) to form carbonic acid (H2CO3), which dissociates into hydrogen ions (H+) and bicarbonate ions (HCO3-).</p>\r\n<p>This system allows the body to regulate pH through:</p>\r\n<ul>\r\n<li>Respiratory control: Adjusting CO2 levels via breathing.</li>\r\n<li>Renal control: Regulating H2 and HCO3- excretion.</li>\r\n</ul>\r\n<p><strong>Option D: </strong>Proteins (e.g., hemoglobin and plasma proteins) act as buffers by binding or releasing H+ ions. For instance, hemoglobin binds H+ ions during oxygen unloading in tissues.</p>\r\n<p>While proteins contribute significantly to buffering, especially in intracellular compartments, they are not the primary buffer system in blood plasma.</p>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Extracellular buffer &ndash; Bicarbonate buffer, most important and major buffer system</li>\r\n<li>Intracellular Buffer &ndash; Phosphate buffer</li>\r\n<li>Buffer in blood &ndash; Plasma protein (albumin) &amp; Hemoglobin in RBC</li>\r\n<li>Urinary buffer &ndash; Phosphate buffer</li>\r\n</ul>",
      "correct_choice_id": 213,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetic ketoacidosis</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactic acidosis</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal failure</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal tubular acidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are the causes of high anion gap metabolic acidosis except</span></p>",
      "unique_key": "DT1296749",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296749,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<p><strong>Option A: </strong>Diabetic ketoacidosis (DKA) causes accumulation of ketoacids (e.g., acetoacetate, beta-hydroxybutyrate) due to unchecked lipolysis in insulin-deficient states. These unmeasured anions increase the anion gap.</p>\r\n<p><strong>Option B: </strong>Lactic acidosis causes accumulation of lactic acid due to hypoxia, shock, sepsis, or mitochondrial dysfunction. Lactate is an unmeasured anion, raising the anion gap.</p>\r\n<p><strong>Option C: </strong>Renal failure leading to accumulation of sulfate, phosphate, and organic acids due to impaired renal clearance. These unmeasured anions increase the anion gap and lead to High Anion Gap Metabolic Acidosis.</p>\r\n<p><strong>Option D: </strong>Renal tubular acidosis (RTA) leads to impaired acid secretion or bicarbonate reabsorption by the renal tubules. Unlike high anion gap causes, the loss of bicarbonate or failure to excrete H+ is counterbalanced by retention of chloride (hyperchloremia), leading to a normal anion gap metabolic acidosis (also called hyperchloremic metabolic acidosis).</p>\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>High AG metabolic acidosis: DKA, lactic acidosis, renal failure.</li>\r\n<li>Normal AG metabolic acidosis: Renal tubular acidosis.</li>\r\n</ul>",
      "correct_choice_id": 224,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with history of asthma, shallow breathing and retains carbon dioxide, leading to a decrease in blood pH (<7.35). Which acid-base imbalance does this represent?</span></p>",
      "unique_key": "DT1296751",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296751,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<p><strong>Option A: </strong>The patient has shallow breathing (likely hypoventilation) and retention of carbon dioxide (CO2), leading to an increase in arterial CO2 levels (hypercapnia).</p>\r\n<p>This condition causes the following changes:</p>\r\n<ul>\r\n<li>Increased CO2: CO<sub>2 </sub>+ H<sub>2</sub>O &harr; H<sub>2</sub>CO<sub>3</sub> &harr; H<sup>+</sup> + HCO3<sup>&minus; </sup> <br />Accumulated CO2 shifts this reaction to the right, increasing hydrogen ion (H+) concentration and decreasing pH.</li>\r\n<li>pH Decrease (&lt; 7.35): The decrease in pH due to CO2 retention classifies this condition as respiratory acidosis.</li>\r\n</ul>\r\n<p><strong>Option B: </strong>Metabolic alkalosis occurs due to loss of acid (e.g., vomiting) or gain of bicarbonate (e.g., overuse of antacids), leading to an increase in pH (&gt;7.45). It is not related to CO2 retention.</p>\r\n<p><strong>Option C: </strong>Respiratory alkalosis occurs when CO2 levels decrease due to hyperventilation (e.g., anxiety, high altitude). The pH increases (&gt;7.45) instead of decreasing.</p>\r\n<p><strong>Option D: </strong>Metabolic acidosis occurs due to an increase in non-volatile acids (e.g., ketoacids in diabetic ketoacidosis) or loss of bicarbonate (e.g., diarrhea). It is unrelated to CO2 retention and shallow breathing.</p>\r\n<p><strong>Detailed explanation</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250116fdb417e5-b60d-419e-8878-f164df92a602.jpg\">\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Hypoventilation leads to Respiratory acidosis characterized by low pH, high pCO2.</li>\r\n<li>Hyperventilation leads to Respiratory alkalosis characterized by high pH, low pCO2.</li>\r\n</ul>",
      "correct_choice_id": 231,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Mineralocorticoid excess</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactic acidosis</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute renal failure</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetic ketoacidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following acid base disorders can lead to hyperkalemia except</span></p>",
      "unique_key": "DT1296753",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296753,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Option wise explanation</strong></p>\r\n<p><strong>Option A: </strong>Excess mineralocorticoids (e.g., aldosterone) promote potassium excretion in the kidneys by increasing sodium reabsorption in exchange for potassium and hydrogen ions. This leads to hypokalemia, not hyperkalemia.</p>\r\n<p><strong>Option B: </strong>In metabolic acidosis (like lactic acidosis), excess hydrogen ions enter cells in exchange for potassium ions, leading to hyperkalemia.</p>\r\n<p><strong>Option C: </strong>Impaired kidney function reduces potassium excretion, leading to its accumulation in the blood. This results in hyperkalemia.</p>\r\n<p><strong>Option D: </strong>Acidosis drives potassium out of cells and into the bloodstream in exchange for hydrogen ions. Additionally, insulin deficiency impairs potassium uptake into cells, further contributing to hyperkalemia.</p>\r\n<p><strong>Detailed explanation</strong></p>\r\n<p><strong>Potassium Overview:</strong></p>\r\n<ul>\r\n<li>Normal range in serum: 3.5&ndash;5.0 mEq/L.</li>\r\n<li>Primary location: Intracellular (98% of total potassium); only ~2% is extracellular.</li>\r\n<li>Crucial for:\r\n<ul>\r\n<li>Nerve conduction and muscle contraction (including the heart).</li>\r\n<li>Maintaining cellular resting membrane potential.</li>\r\n<li>Acid-base balance via exchange with hydrogen ions.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Hypokalemia (Serum K+ &lt; 3.5 mEq/L):</strong></p>\r\n<p>Causes:</p>\r\n<ol>\r\n<li>Increased loss:\r\n<ul>\r\n<li>Gastrointestinal: Vomiting, diarrhea, laxative abuse.</li>\r\n<li>Renal: Diuretics (e.g., loop and thiazides), hyperaldosteronism, renal tubular disorders.</li>\r\n</ul>\r\n</li>\r\n<li>Shift into cells:\r\n<ul>\r\n<li>Alkalosis (H+ leaves cells, K+ enters).</li>\r\n<li>Insulin administration (stimulates K+ uptake by cells).</li>\r\n<li>Beta-agonists (e.g., salbutamol).</li>\r\n</ul>\r\n</li>\r\n<li>Inadequate intake: Rare but can occur with starvation or prolonged fasting.</li>\r\n</ol>\r\n<p>Clinical Features:</p>\r\n<ul>\r\n<li>Muscle weakness or cramps.</li>\r\n<li>Arrhythmias: Prolonged QT interval, U waves on ECG.</li>\r\n<li>Paralysis in severe cases.</li>\r\n<li>Polyuria and polydipsia due to impaired renal function.</li>\r\n</ul>\r\n<p>Management:</p>\r\n<ul>\r\n<li>Replace potassium (oral or IV depending on severity).</li>\r\n<li>Correct underlying cause.</li>\r\n</ul>\r\n<p><strong>Hyperkalemia (Serum K+ &gt; 5.0 mEq/L):</strong></p>\r\n<p>Causes:</p>\r\n<ol>\r\n<li>Reduced excretion:\r\n<ul>\r\n<li>Acute or chronic kidney failure.</li>\r\n<li>Hypoaldosteronism (e.g., Addison&rsquo;s disease).</li>\r\n<li>Medications: ACE inhibitors, ARBs, potassium-sparing diuretics.</li>\r\n</ul>\r\n</li>\r\n<li>Shift out of cells:\r\n<ul>\r\n<li>Acidosis (H+ enters cells, K+ exits).</li>\r\n<li>Cell lysis: Trauma, hemolysis, tumor lysis syndrome, burns.</li>\r\n<li>Insulin deficiency.</li>\r\n</ul>\r\n</li>\r\n<li>Excessive intake: Rare unless kidney function is impaired.</li>\r\n</ol>\r\n<p>Clinical Features:</p>\r\n<ul>\r\n<li>Muscle weakness or paralysis.</li>\r\n<li>Cardiac effects:</li>\r\n<ul>\r\n<li>Peaked T waves, widened QRS complex, sine wave pattern in severe cases.</li>\r\n<li>Risk of ventricular fibrillation or asystole.</li>\r\n</ul>\r\n<li>Tingling or numbness in severe cases.</li>\r\n</ul>\r\n<p>Management:</p>\r\n<ul>\r\n<li>Stabilize the heart: IV calcium gluconate.</li>\r\n<li>Shift potassium into cells: Insulin with glucose, beta-agonists, sodium bicarbonate (if acidosis is present).</li>\r\n<li>Remove excess potassium: Diuretics, dialysis, or potassium-binding resins (e.g., sodium polystyrene sulfonate).</li>\r\n</ul>\r\n<p><strong>Key Differences between Hypokalemia &amp; Hyperkalemia:</strong></p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250116ca2ba49a-b98e-4e0d-8b86-8843b4da1d74.jpg\">\r\n<p><strong>Key take away</strong></p>\r\n<ul>\r\n<li>Normal potassium range in serum: 3.5&ndash;5.0 mEq/L.</li>\r\n<li>Major intracellular cation</li>\r\n<li>Relationship of potassium with Acid-Base Balance:</li>\r\n</ul>\r\n<p>Acidosis: Causes hyperkalemia (K+ moves out of cells in exchange for H+ entering).</p>\r\n<p>Alkalosis: Causes hypokalemia (K+ moves into cells in exchange for H+ exiting).</p>",
      "correct_choice_id": 241,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}